Skip to main content
Premium Trial:

Request an Annual Quote

To Test or Not to Test?

A proposal is making the rounds of the NCAA's Division I teams to test all athletes for sickle cell trait, according to an article in the New York Times. But the measure is being disputed by some groups, such as the Sickle Cell Disease Association of America, that say the results could be used to discriminate against athletes who test positive for the disease, and that changing training practices would be enough to lower their risk of death. Some of the most influential football conferences — including the Pacific-10 and the Big East — oppose mandatory testing, the article says, but some schools test for the disease. A 2006 survey of athletic programs found that 21 percent of the 92 respondents screened all athletes for sickle cell trait, the New York Times says. But the worry is that even if the athletes are allowed to play in college, their prospects for the NFL will be dimmed if they come attached with a positive test result. Changing training practices, as the Army did after it stopped testing for sickle cell trait, may the best solution to protect all athletes from the overexertion, the article says.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.